The document discusses how the UK pharmaceutical industry can build greater trust with the NHS. It recommends developing a peer-to-peer relationship based on shared value exchange, understanding each other's strategies, and maintaining contact across all levels and functions. This relationship should be built on trust, co-working toward a shared vision, and integrity. Trust can be developed by understanding needs, following through on commitments, solving problems, providing access, and personal contact.